ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 0195

Epidemiology and Characteristics of Incident Rheumatoid Arthritis in Persons with and Without HIV

Jennifer Hanberg1, Kathleen Akgun2, Liana Fraenkel3, Evelyn Hsieh2 and Amy Justice4, 1Yale University School of Medicine; West Haven VA, Boston, MA, 2Yale University School of Medicine; West Haven VA, New Haven, CT, 3Yale School of Medicine; West Haven VA; Berkshire Medical Center, Lenox, MA, 4Yale University School of Medicine; Yale School of Public Health; West Haven VA, West Haven, CT

Meeting: ACR Convergence 2020

Keywords: Anti-citrullinated Protein Autoantibodies (ACPAs), Autoantibody(ies), immunology, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Friday, November 6, 2020

Session Title: RA – Diagnosis, Manifestations, & Outcomes Poster I: Multimorbidity

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Rheumatoid arthritis (RA) is the most common chronic inflammatory arthritis, affecting 1-2% of the population. Estimates of the incidence of RA in patients with HIV (PWH) are sparse, as are data regarding the presentation of RA in PWH.

Methods: Patients were selected from the Veterans Aging Cohort Study, a longitudinal cohort of Veterans with HIV and age, sex, race, and site-of-care-matched 1:2 to uninfected Veterans.  Between 1997-2017, we searched all International Classification of Diseases (ICD) codes starting from each patient’s first entry into the medical record, or in cases of PWH, from the time of diagnosis of HIV. We identified patients with ≥1 outpatient rheumatology clinic ICD code for RA and a positive or negative rheumatoid factor (RF) or anti-CCP antibodies. Charts were reviewed using the 2010 RA Classification Criteria; a score of  ≥6 was classified as incident RA if there was no evidence of prior diagnosis, such as listing of RA as past medical history. We recorded conventional and biologic disease-modifying anti-rheumatic drug (DMARD) use, and reasons for changes in therapy during the first contiguous course of therapy (period with no interruption greater than 6 months).

Results: We included 56,250 PWH and 116,944 uninfected persons over 2,384,541 person-years. Of 2,748 patients with an ICD code for RA, 1,030 (37%) had at least one rheumatologist-generated ICD code and 881 (32%) had serology available. “Definite” incident RA was identified in 215 cases, 21 of whom were PWH at the time of RA diagnosis. The crude incidence of RA was 0.33 cases per 10,000 person-years (95% CI, 0.21-0.51) in PWH vs. 1.11 (0.96-1.28) in patients without. The incidence rate ratio of RA in PWH vs. uninfected was 0.29 (95% CI 0.19-0.48, p< 0.0001). Among PWH with incident RA, the median CD4 count closest to diagnosis was 487 cells/mm3 (25th-75th percentile, 367-650), and 81% of patients with recent HIV-1 viral titers available had levels less than 500 copies/mL. Most patients (88%) with incident RA were seropositive. However, high antibody titers were found less frequently in PWH: 5% of PWH had both a high (≥3 times upper limit of normal) anti-CCP titer and a high RF titer, compared to 41% of persons without HIV (Table). DMARDs were prescribed for 71% of PWH with “definite” RA, compared to 94% of uninfected Veterans (p=0.0002). The most commonly used DMARD among PWH was HCQ (57%) while methotrexate was more common in uninfected Veterans (66%). PWH were significantly less likely to be prescribed methotrexate (33% vs. 66%, p=0.004), leflunomide (0% vs. 12%, p=0.01), and biologic or small molecule drugs (10% vs. 32%, p=0.02).

Conclusion: Incident RA was less common in PWH than in matched uninfected persons. PWH with incident RA were less likely to have strongly positive autoantibody profiles than uninfected individuals.

Table: Anti-CCP and Rheumatoid Factor Serologies Were More Strongly Positive in Uninfected than in PWH with Incident RA. High positive was defined in accordance with the 2010 RA Classification Criteria as at least 3 times the upper limit of normal per the local laboratory value. Low positive was defined as a result greater than the upper limit of normal but less than 3 times this value, or an unquantified positive result.


Disclosure: J. Hanberg, None; K. Akgun, None; L. Fraenkel, None; E. Hsieh, None; A. Justice, None.

To cite this abstract in AMA style:

Hanberg J, Akgun K, Fraenkel L, Hsieh E, Justice A. Epidemiology and Characteristics of Incident Rheumatoid Arthritis in Persons with and Without HIV [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/epidemiology-and-characteristics-of-incident-rheumatoid-arthritis-in-persons-with-and-without-hiv/. Accessed February 3, 2023.
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/epidemiology-and-characteristics-of-incident-rheumatoid-arthritis-in-persons-with-and-without-hiv/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2023 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences